<DOC>
	<DOCNO>NCT01194986</DOCNO>
	<brief_summary>The purpose study investigate feature radioligand [ 11C ] AZ12807110 much AZD5213 displaces radioligand histamine receptor give together .</brief_summary>
	<brief_title>Evaluation Histamine H3 Receptor Radioligand 11CAZ12807110 Histamine H3 Receptor Occupancy AZD5213 After Oral Administration</brief_title>
	<detailed_description />
	<mesh_term>Histamine</mesh_term>
	<mesh_term>Histamine phosphate</mesh_term>
	<criteria>Healthy male and/or female volunteer 20 45 year suitable vein cannulation repeat venipuncture ( pilot panel ) Female must nonchild bear potential ( pilot panel ) BMI 18 30 30 kg/m2 Normal MRI scan Provision sign , write date informed consent History clinically significant disease disorder History presence gastrointestinal , hepatic renal disease Prolonged QTcF &gt; 450 m shorten QTcF &lt; 340 m family history long QT syndrome History severe allergy hypersensitivity ongoing allergy hypersensitivity Healthy volunteer suffers claustrophobia</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Receptor binding</keyword>
	<keyword>Histamine H3 receptor</keyword>
	<keyword>binding</keyword>
	<keyword>radioligand</keyword>
</DOC>